earnings
MC
NASDAQ · MCRB
Seres Therapeutics, Inc.
Healthcare · Biotechnology
$4.72
Down-$0.24 (-5.08%)
Updated Aug 13, 2026, 10:05 PM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 151.06M
- P/E ratio
- 27.95
- Dividend yield
- 0.00%
- 52-week range
- $4.59 – $29.98
- Volume
- 45.37K
- Avg. volume
- 192.86K
Price performance
MCRB price history
1M range · 21 trading sessions · Daily adjusted prices
MCRB closed at $4.72 after 21 trading sessions, down 13.39% for the selected period.
- Last close
- $4.72
- Period change
- -13.39%
- Period low
- $4.64
- Period high
- $5.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $4.63 | $4.7671 | $4.585 | $4.72 | 45.37K |
| Aug 11, 2026 | $4.94 | $4.94 | $4.615 | $4.64 | 84.68K |
| Aug 10, 2026 | $5.05 | $5.05 | $4.76 | $5.00 | 84.6K |
| Aug 7, 2026 | $5.07 | $5.1894 | $4.82 | $4.87 | 62.32K |
| Aug 6, 2026 | $5.01 | $5.15 | $4.70 | $4.82 | 80.16K |
| Aug 5, 2026 | $5.63 | $5.65 | $4.82 | $5.005 | 141.75K |
| Aug 4, 2026 | $5.07 | $5.40 | $4.81 | $5.25 | 40.46K |
| Aug 3, 2026 | $4.90 | $5.13 | $4.90 | $5.03 | 29.85K |
| Jul 31, 2026 | $4.86 | $4.99 | $4.645 | $4.83 | 51.18K |
| Jul 30, 2026 | $4.77 | $4.90 | $4.60 | $4.78 | 50.38K |
| Jul 29, 2026 | $4.74 | $4.91 | $4.63 | $4.65 | 53.11K |
| Jul 28, 2026 | $4.84 | $5.01 | $4.59 | $4.80 | 63.36K |
| Jul 27, 2026 | $4.98 | $5.29 | $4.85 | $4.85 | 67.62K |
| Jul 24, 2026 | $5.22 | $5.44 | $4.92 | $4.965 | 84.53K |
| Jul 23, 2026 | $5.21 | $5.36 | $5.11 | $5.23 | 29.82K |
| Jul 22, 2026 | $5.27 | $5.33 | $5.17 | $5.28 | 28.77K |
| Jul 21, 2026 | $5.16 | $5.325 | $5.10 | $5.25 | 26.94K |
| Jul 20, 2026 | $5.36 | $5.36 | $5.00 | $5.11 | 48.94K |
| Jul 17, 2026 | $5.13 | $5.69 | $5.13 | $5.33 | 56.36K |
| Jul 16, 2026 | $5.42 | $5.5996 | $5.115 | $5.18 | 84.14K |
| Jul 15, 2026 | $5.36 | $5.54 | $5.21 | $5.45 | 30.99K |
Latest MCRB news
The latest Smart Investors Daily articles mentioning MCRB.
Stock researchResearch & News · SEC Filings
Loading stock research…

